HBK Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-13,700
| Closed | -$1.55M | – | 901 |
|
|
2018
Q4 | $1.55M | Buy |
+13,700
| New | +$1.55M | 0.02% | 488 |
|
|
2017
Q4 | – | Sell |
-3,892
| Closed | -$420K | – | 931 |
|
|
2017
Q3 | $420K | Buy |
3,892
+1,872
| +93% | +$202K | ﹤0.01% | 763 |
|
|
2017
Q2 | $204K | Sell |
2,020
-5,992
| -75% | -$605K | ﹤0.01% | 816 |
|
|
2017
Q1 | $721K | Sell |
8,012
-28,125
| -78% | -$2.53M | 0.01% | 404 |
|
|
2016
Q4 | $2.75M | Buy |
36,137
+33,437
| +1,238% | +$2.55M | 0.03% | 233 |
|
|
2016
Q3 | $225K | Buy |
+2,700
| New | +$225K | ﹤0.01% | 709 |
|
|
2016
Q2 | – | Sell |
-17,777
| Closed | -$1.35M | – | 909 |
|
|
2016
Q1 | $1.35M | Buy |
+17,777
| New | +$1.35M | 0.01% | 466 |
|
|
2014
Q3 | – | Sell |
-15,000
| Closed | -$803K | – | 898 |
|
|
2014
Q2 | $803K | Buy |
+15,000
| New | +$803K | 0.02% | 520 |
|